Cardiac Marker Analyzer Market & Product Analysis, By Analyzers (Alere Meterpro Analyzer, RAMP 200, RAMP Reader, etc) & Companies

1.    Executive Summary

2.    Cardiac Marker Analyzer Market (2011 – 2024)

3.    Cardiac Marker Companies – Comparative Tests Analysis

4.    Cardiac Marker Analyzer – Competitive Product Analysis

5.    Alere

5.1    Alere Triage

5.1.1    Triage MeterPro Analyzer

5.2    Alere Cardiology Net Sales & Forecast (2011 - 2022)

6.    Response Biomedical

6.1    Cardiovascular Testing

6.1.1    Acute Myocardial Infarction (Heart Attack) Testing
6.1.2    Congestive Heart Failure (“CHF”) Testing
6.1.3    Thrombotic Disease Testing

6.2    RAMP Platform

6.2.1    RAMP 200
6.2.2    RAMP Reader

6.3    Response Biomedical Cardiovascular Net Sales

7.    Abbott Point of Care

7.1    The i–STAT System

7.2    Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2024)

8.    Roche

8.1    Cobas h 232 POC System

9.    Siemens Healthineers

9.1    Stratus CS Analyzer

9.2    Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

10.    Beckman Coulter

10.1    Access 2 Immunoassay System

11.    Boditech

11.1    i–chroma DUO Analyzer

12.    Lifesign

12.1    DXpress Reader Analyzer

13.    LSI Medience Corporation

13.1    PATHFAST Analyzer

14.    Trinity Biotech

14.1    Meritas POC Analyzer

14.2    Trinity Biotech Point of Care Diagnostics Sales (2011 – 2024)

15.    CardioGenics Holdings Inc.

15.1    QL Care Analyzer

16.    Mergers, Acquisitions and Licensing Agreements

16.1    Alere Inc

16.2    Response Biomedical

16.3    Abbott Laboratories

16.4    Siemens Healthineers

16.5    LSI Medience Corporation

16.6    Trinity Biotech

16.7    CardioGenics

17.    Emerging Markers

18.    Response Biomedical – Business & Marketing Strategy

18.1    Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy

18.2    New Distributors in China

18.3    Strategic Alliances with Alere Medical in Japan

18.4    Response Biomedical Receives Health Canada Approval and CE Mark

19.    Roche – Business & Marketing Strategy

19.1    Implementing the Fully Connected Core Laboratory

19.2    Expansion of Rich Test Menu

19.3    Broadening the Diagnostics Portfolio

19.4    Patient Safety Comes First

20    Siemens Healthineers – Business and Marketing Strategy

20.1    Siemens Healthineers Announces New Strategic Relationship

20.2    Cloud-Based Network Teamplay from Siemens Healthineers

20.3    Strategic Partnership between Siemens and Imricor

20.4    Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay

20.5    Siemens Healthineers & Digitalization

20.6    Partnership between Siemens Healthineers and Ebit

21.    Boditech Med Inc – Business and Marketing Strategy

21.1    Boditech Med Acquires Immunostics

21.2    Strong Focus on Manpower and Investments in Research & Development Area

21.3    Advanced Technology in the Diagnostics Market

21.4    Marketing Channel

List of Figures:

Figure 2‑1: Global – Cardiac Marker Market (Billion US$), 2011 - 2017
Figure 2‑2: Global – Forecast For Cardiac Marker Market (Billion US$), 2018 – 2024

Figure 5‑1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016

Figure 6‑1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016

Figure 7‑1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2017
Figure 7‑2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2018 – 2024

Figure 8‑1: WIFI Set-up
Figure 8‑2: QR CODE VIA BARCODE SCANNER Set-up
Figure 8‑3: QR CODE VIA SMART PHONE APP Set-up
Figure 8‑4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up

Figure 14‑1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2017
Figure 14‑2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2018 – 2024

Figure 21‑1: Boditech – R&D Manpower, Jan 2016
Figure 21‑2: Boditech – R&D Investments (Million US$), Jan 2016

List of Tables:

Table 2‑1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2‑2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2‑3: Cardiac Marker Companies – Comparative Tests Analysis

Table 3‑1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3‑2: Cardiac Marker Analyzer – Competitive Product Analysis

Table 6‑1: i-STAT 1 Analyzer Specification

Table 12‑1: PATHFAST – Technical Specifications

Table 15‑1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017

Table 18‑1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
Table 18‑2: Roche - Molecular Diagnostics Product Launches, 2017
Table 18‑3: Roche - Tissue Diagnostics Product Launches, 2017
Table 18‑4: Roche - Sequencing Product Launches, 2017